DS

David Schenkein

Hematologist, General Partner and Co-Head Life Science @ GV,

Boston, Massachusetts

Invests in

  • Min Investment:

    $250,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Education

Work Experience

2019

  • General Partner

    2019

  • Board Member

    2023

  • Clinical Professor of Medicine

    2009

  • Board Member

    2022

  • Chairperson of the Board

    2019 - 2022

  • CEO

    2009 - 2019

  • Board Member

    2015

2006 - 2009

  • Senior Vice President, Clinical Hematology/Oncology

    2006 - 2009

Millennium Pharmaceuticals

2001 - 2006

  • Senior Vice President, Clinical Research

    2001 - 2006